Impact Frameworks & Case Studies
Our work is confidential and our impact is strategic. We do not disclose client names. We share the problems we solve and the frameworks we deploy.
These briefs are available for R&D Directors, Clinical Operations Leads, and Policy Makers.
Biomechanical & Protocol Risks in Maxillofacial Prosthetics
Biomechanical Failure Points in Maxillofacial Prosthetics
The Challenge:
Standard safety protocols for maxillofacial rehabilitation often fail to account for the unique pneumatics of Anterior Maxillary Defects. A standard clinical workflow, like using a Low Volume Suction (LVE) tube, can inadvertently create a life-threatening asphyxiation risk.
The Insight:
By running a "Bio-Fidelity Simulation," we analysed the "Cantilever Effect" and asymmetric bite-force distribution on the prosthesis. This revealed critical failure points in both the device design and the clinical handling protocol.
The Impact:
Identified a fatal flaw: Uncovered the "Pneumatic Short-Circuit" risk in standard suction protocols.
Redesigned the workflow: Established the "5-Hand Procedure" to mitigate suffocation risk during impression taking.
Pinpointed design failure: Mapped the biomechanical stress points (the "Cantilever Effect") that lead to device rejection and pain.
Global Health Advocacy: The Noma (NTD) Case
The Challenge:
A neglected disease (Noma) was causing massive mortality and an estimated $3.5 Billion in economic loss, yet remained invisible to global health institutions.
The Insight:
A traditional "awareness" campaign was insufficient.
A multi-year, survivor-led advocacy strategy was required, targeting the highest levels of global governance (the WHO) and building a coalition of strategic partners (like Swiss TPH and MSF).
The Impact:
Achieved the "Impossible":
Executed a successful global lobbying strategy resulting in the WHO's official recognition of Noma as a Neglected Tropical Disease.
Secured Funding:
Facilitated multi-six-figure strategic funding for key academic research partners to ensure the continuation of vital policy and medical work.
Ethical Governance: De-Risking Patient Engagement
Ethical Governance:
De-Risking Patient Engagement
The Challenge:
A client's "Patient-Led" advisory board was failing. It was plagued by performative tokenism, causing survivor burnout and creating a significant reputational risk for the company.
The Insight:
The board lacked a legal and ethical "fortress." It was a marketing exercise, not a governance function.
The Impact:
Deployed the "Ethical Fortress":
We implemented our proprietary Master Services Agreement (MSA).
Monetised Respect:
We established a CHF 10,000 "Respect Fine" for discriminatory behavior and a CHF 75,000 "Poison Pill" for any breach of story integrity.
Banned Tokenism:
We enforced an "Anti-Tokenism" clause , legally protecting our advisors' right to refuse performative work while still being paid.